Meyka AI API is live for developers.Start building.
Advertisement
Satellos Bioscience Inc.

Satellos Bioscience Inc. (MSLE) Stock Overview

Explore Satellos Bioscience Inc.’s financial performance, market position, analyst ratings, and future outlook.

MSLE●NASDAQ
HealthcareMedical - Pharmaceuticals
$7.76
$1.05(15.63%)
U.S. Market is Open · 10:07
Advertisement

Satellos Bioscience Inc. (MSLE)

Meyka AI Score

Z

Key Financials

Market Cap9.1M
P/E Ratio-4.00
EPS (TTM)$-1.36
ROE-0.67%
Fundamental Analysis

AI Price Forecasts

1 Month$3.35
3 Months$0.00
1 Year Target$0.00

MSLE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Satellos Bioscience Inc. (MSLE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.00 and a market capitalization of 9.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.50%
5-Day Change
23.78%
1-Month Change
3.96%
3-Month Change
2.16%
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

https://satellos.com
1 647 660 1780
Royal Bank Plaza, Toronto, ON, M5J 2J1

Company Facts

180 Employees
IPO DateAug 3, 2012
CountryCA
Actively Trading

Frequently Asked Questions